Cholangiocarcinoma of the Gallbladder Completed Phase 1 Trials for Cisplatin (DB00515)

IndicationStatusPhase
DBCOND0029558 (Cholangiocarcinoma of the Gallbladder)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01825603ADH-1, Gemcitabine Hydrochloride and Cisplatin in Treating Patients With Locally Advanced or Metastatic Pancreatic or Biliary Tract Cancer That Cannot Be Removed by SurgeryTreatment
NCT00949949Everolimus, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Unresectable Solid Tumors Refractory to Standard TherapyTreatment